Healthcare -
Biotechnology - NASDAQ - US
$ 6.545
-4.64 %
$ 654 M
Market Cap
-14.0
P/E
TRVI - EPS
EPS TRVI - Trevi Therapeutics, Inc.
-0.47
LAST VALUE
-2.20%
2 YEAR CAGR
26.69%
5 YEAR CAGR
0.00%
10 YEAR CAGR